Filamin C dimerisation is regulated by HSPB7
Abstract
Abstract The biomechanical properties and responses of tissues underpin a variety important of physiological functions and pathologies. In striated muscle, the actin-binding protein filamin C (FLNC) is a key protein whose variants causative for a wide range of cardiomyopathies and musculoskeletal pathologies. FLNC is a multi-functional protein that interacts with a variety of partners, however, how it is regulated at the molecular level is not well understood. Here we investigate its interaction with HSPB7, a cardiac-specific molecular chaperone whose absence is embryonically lethal. We find that FLNC and HSPB7 interact in cardiac tissue under biomechanical stress, forming a strong hetero-dimer whose structure we solve by X-ray crystallography. Our quantitative analyses show that the hetero-dimer out-competes the FLNC homo-dimer interface, potentially acting to abrogate the ability of the protein to cross-link the actin cytoskeleton, and to enhance its diffusive mobility. We show that phosphorylation of FLNC at threonine 2677, located at the dimer interface and associated with cardiac stress, acts to favour the homo-dimer. Conversely, phosphorylation at tyrosine 2683, also at the dimer interface, has the opposite effect and shifts the equilibrium towards the hetero-dimer. Evolutionary analysis and ancestral sequence reconstruction reveals this interaction and its mechanisms of regulation to date around the time primitive hearts evolved in chordates. Our work therefore shows, structurally, how HSPB7 acts as a specific molecular chaperone that regulates FLNC dimerisation.
Article Details
Authors (27)
Zihao Wang
Guodong Cao
Miranda P. Collier
Xingyu Qiu
Sophie Broadway-Stringer
Dominik Šaman
Jediael Z. Y. Ng
Navoneel Sen
Kavli Institute for Nanoscience Discovery, University of Oxford
Amar J. Azad
Charlotte Hooper
Johannes Zimmermann
Michael A. McDonough
Jürgen Brem
Patrick Rabe
Haigang Song
T. Reid Alderson
Helmholtz Munich, Molecular Targets and Therapeutics Center, Institute of Structural Biology
Christopher J. Schofield
Jani R. Bolla
Department of Biology, Univeristy of Oxford
Kristina Djinovic-Carugo
Dieter O. Fürst
Bettina Warscheid
Biochemistry II, Theodor Boveri-Institute, Biocenter Faculty of Chemistry and Pharmacy, University of Würzburg
Matteo T. Degiacomi
Timothy M. Allison
Georg K. A. Hochberg
Carol V. Robinson
Kavli Institute for Nanoscience Discovery
Katja Gehmlich
Justin L. P. Benesch
Kavli Institute for Nanoscience Discovery, University of Oxford